Honjo, A.; Yako, H.; Miyamoto, Y.; Yagi, M.; Yamamoto, M.; Nishi, A.; Sakagami, H.; Yamauchi, J.
Knocking Down FRMD4A, a Factor Associated with the Brain Development Disorder and a Risk Factor for Alzheimer’s Disease, Using RNA-Targeting CRISPR/Cas13 Reveals Its Role in Cell Morphogenesis. Int. J. Mol. Sci. 2025, 26, 10083.
https://doi.org/10.3390/ijms262010083
AMA Style
Honjo A, Yako H, Miyamoto Y, Yagi M, Yamamoto M, Nishi A, Sakagami H, Yamauchi J.
Knocking Down FRMD4A, a Factor Associated with the Brain Development Disorder and a Risk Factor for Alzheimer’s Disease, Using RNA-Targeting CRISPR/Cas13 Reveals Its Role in Cell Morphogenesis. International Journal of Molecular Sciences. 2025; 26(20):10083.
https://doi.org/10.3390/ijms262010083
Chicago/Turabian Style
Honjo, Asahi, Hideji Yako, Yuki Miyamoto, Moeri Yagi, Masahiro Yamamoto, Akinori Nishi, Hiroyuki Sakagami, and Junji Yamauchi.
2025. "Knocking Down FRMD4A, a Factor Associated with the Brain Development Disorder and a Risk Factor for Alzheimer’s Disease, Using RNA-Targeting CRISPR/Cas13 Reveals Its Role in Cell Morphogenesis" International Journal of Molecular Sciences 26, no. 20: 10083.
https://doi.org/10.3390/ijms262010083
APA Style
Honjo, A., Yako, H., Miyamoto, Y., Yagi, M., Yamamoto, M., Nishi, A., Sakagami, H., & Yamauchi, J.
(2025). Knocking Down FRMD4A, a Factor Associated with the Brain Development Disorder and a Risk Factor for Alzheimer’s Disease, Using RNA-Targeting CRISPR/Cas13 Reveals Its Role in Cell Morphogenesis. International Journal of Molecular Sciences, 26(20), 10083.
https://doi.org/10.3390/ijms262010083